Marked increase of MAZ mRNA is observed at the terminal phase of human chronic myelogenous leukemia (CML) and an increased transcription from the MAZ gene has been closely linked to the malignant phenotype of this disease 20. Here, MAZ is linked to chronic myelogenous leukemia, BCR-ABL1 positive.